NSC |
Compound |
Enrichment |
Correlation |
NSC 625154 |
21-Oxabicyclo[16.2.1]heneicosane-4,9,14,18,20-pentaene, 3,6,8,11,13,16-hexaoxo-2,2,7,7,,12,12,17,17-octamethyl- |
0.0241085022307781 |
0.59969295 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0247979034812109 |
0.24183897 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0247979034812109 |
0.262625 |
NSC 30722 |
Pyrimidine, 2,4,6-trichloro-5-methyl- |
0.0247979034812109 |
0.46024099 |
NSC 339137 |
PHYSALOLACTONE |
0.0247979034812109 |
0.39062888 |
NSC 339579 |
7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate |
0.0247979034812109 |
0.12794488 |
NSC 372155 |
2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- |
0.0247979034812109 |
0.38640739 |
NSC 39215 |
Null |
0.0247979034812109 |
0.60156264 |
NSC 601518 |
Null |
0.0247979034812109 |
0.58554289 |
NSC 636969 |
Null |
0.0247979034812111 |
0.3600597 |